StemCyte (4178.TW) monthly revenue, September 2026

Name: StemCyte (4178) monthly revenue 2026-09 | Value Ledger
Creator: Value Ledger
License: https://creativecommons.org/licenses/by/4.0/

StemCyte reported revenue of NT$30.7 million for September 2026, down 3.9% from the previous month and up 28.2% from a year earlier. Year-to-date revenue was NT$279.5 million, up 2.7% year on year. It ranked 43 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

Month	Revenue NT$bn	MoM %	YoY %
September 2026	0.03	-3.9	28.2